This study, which reviewed how 783 adults responded when taking tirzepatide for 36 weeks, found that a subgroup of 335 who were taken off the drugs and switched to a placebo for about a year regained an average of 14% of their total body weight, while another group who continued to take GLP-1 medications lost another 5.5%
It acts as a lipotropic agent to prevent excess fat buildup in the liver and the body
Research in chronic wound modelsincluding diabetic and pressure ulcer experimental systems that had failed standard healing protocolsdemonstrates that TB-500 administration achieves closure rates of 75-85% compared to 35-45% with standard approaches, highlighting potential for addressing impaired healing scenarios
Researchers in the SURMOUNT-1 body composition substudy found that tirzepatide-treated participants lost 33.9% of their fat mass compared to 8.2% in the placebo group
doi: 10.2147/DDDT.S100795 40 MiceliM
Mix & match different products at 20+ vials | Discounts apply automatically at checkout In stock $59.99 Original price was: $59.99.$41.99Current price is: $41.99